
AOA Dx
Blood Test for Early Detection of Ovarian Cancer
About
AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.
Topics
- Location
- Denver, CO, United States
- Team size
- 25 employees
- YC batch
- Summer 2021
- Status
- Active
- Stage
- Early stage





